Terns Pharmaceuticals, Inc.
Recent Filings
All 398 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| SC TO-C | SC TO-C | Mar 26, 2026 |
| SC14D9C | SC14D9C | Mar 25, 2026 |
| SC TO-C | SC TO-C | Mar 25, 2026 |
| SC14D9C | SC14D9C | Mar 25, 2026 |
| SC TO-C | SC TO-C | Mar 25, 2026 |
| 8-K | 8-K | Mar 25, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 17, 2026 |
| 4 | PRIMARY DOCUMENT | Feb 18, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Kuriakose Emil | Chief Medical Officer | Sale | 944 @ $7.85 | 51,520 | Oct 1, 2025 |
| Kuriakose Emil | Chief Medical Officer | Sale | 853 @ $4.27 | 52,464 | Jul 1, 2025 |
| Gengos Andrew | Chief Financial Officer | Purchase | 5,000 @ $3.93 | 20,000 | Jun 27, 2025 |
| Burroughs Amy L. | Chief Executive Officer | Purchase | 23,314 @ $3.87 | 47,083 | Jun 25, 2025 |
| Gengos Andrew | Chief Financial Officer | Purchase | 5,000 @ $3.72 | 10,000 | Jun 16, 2025 |
| Kuriakose Emil | Chief Medical Officer | Sale | 952 @ $2.49 | 53,317 | Apr 1, 2025 |
| Vignola Mark J. | Chief Financial Officer | Sale | 8,129 @ $5.72 | 83,811 | Jan 6, 2025 |
| Quigley Jill M. | — | Sale | 6,240 @ $5.72 | 8,760 | Jan 6, 2025 |
| Kuriakose Emil | Chief Medical Officer | Sale | 4,481 @ $5.71 | 54,269 | Jan 2, 2025 |
| Burroughs Amy L. | Chief Executive Officer | Purchase | 15,450 @ $7.15 | 19,099 | Dec 5, 2024 |